Tobacco News and Research

RSS

Celgene to share new and updated data around novel hematological therapies

Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.

22 May 2018

Vitamin C consumption may reduce harm to baby's lungs due to smoking during pregnancy

Women who are unable to quit smoking during their pregnancy may reduce the harm smoking does to their baby's lungs by taking vitamin C, according to a new randomized, controlled trial presented at the ATS 2018 International Conference.

22 May 2018

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. This is the first drug approved by the FDA for this use.

22 May 2018

Study examines link between nicotine dependence and likelihood to quit smoking after lung cancer screening

Tobacco cessation is considered the single most effective primary prevention strategy for reducing the risk of lung cancer death in patients.

22 May 2018

Researchers discover new disease mechanism in chronic tobacco smokers

Research published in the journal Clinical Science suggests that an immune signaling protein called interleukin-26 is increased among chronic smokers with lung disease and this involvement reveals disease mechanisms of interest for developing more effective therapy for these hard-to-treat patients.

21 May 2018

Experts available to discuss subjects related to Ebola virus

Georgetown University Medical Center (GUMC) professors offer expertise for journalists seeking interviews in a variety of subjects related to Ebola.

18 May 2018

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults.

17 May 2018

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

16 May 2018

First, marijuana. Are magic mushrooms next?

In Oregon and Denver, where marijuana is legal for recreational use, activists are now pushing toward a psychedelic frontier: "magic mushrooms."

14 May 2018

FDA approves new drug to treat MS in pediatric patients

The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.

14 May 2018

Prenatal marijuana use can have consequences on infants' weight and behavior

Smoking during pregnancy has well-documented negative effects on birth weight in infants and is linked to several childhood health problems.

10 May 2018

FDA seeks order of permanent injunction to stop two stem cell clinics from marketing stem cell products

The U.S. Food and Drug Administration, in two complaints filed today in federal court, is seeking permanent injunctions to stop two stem cell clinics from marketing stem cell products without FDA approval and for significant deviations from current good manufacturing practice requirements.

10 May 2018

Lesbian, bisexual women have higher risk of developing type 2 diabetes, finds study

In a newly published study involving 94,250 women across the United States, researchers found that lesbian and bisexual (LB) women were more likely than heterosexual women to develop type 2 diabetes during the course of the 24-year study follow up.

10 May 2018

HCI announces opening of Center for HOPE for improving health among underserved populations

Huntsman Cancer Institute at the University of Utah today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity, a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients.

9 May 2018

Study links occupational exposures with higher incidence of COPD

An international team led by researchers from the Barcelona Institute for Global Health, a center supported by the "la Caixa" Foundation, has provided new evidence about the role of occupational exposures as an important risk factor for Chronic Obstructive Pulmonary Disease.

9 May 2018

Scientists use X-ray laser to gain insights into structure of Alzheimer's proteins

A new experimental method permits the X-ray analysis of amyloids, a class of large, filamentous biomolecules which are an important hallmark of diseases such as Alzheimer's and Parkinson's.

9 May 2018

Huntsman Cancer Institute opens Cancer Population Sciences and Huntsman Center for HOPE

Huntsman Cancer Institute (HCI) at the University of Utah (U of U) today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity (HOPE), a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients.

9 May 2018

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot be removed by surgery or has spread to other parts of the body (metastatic), and has a type of abnormal gene, BRAF V600E (BRAF V600E mutation-positive).

8 May 2018

Five facts to help teens make informed decisions about vaping

"Juuling" is the latest trend among high school students but do teens know what they're inhaling? The "Juul" is a type of e-cigarette device that dispenses a potent dose of nicotine when the user inhales. Unlike an e-cigarette, the slickly designed device resembles a small USB flash drive and creates very little smoke so it is not easily detected by teachers and parents.

8 May 2018

FDA authorizes marketing of Hemospray device for treating GI bleeding

Today, the U.S. Food and Drug Administration permitted marketing of Hemospray, a new device used to help control certain types of bleeding in the gastrointestinal (GI) tract.

8 May 2018

Tobacco News and Research

Celgene to share new and updated data around novel hematological therapies

Vitamin C consumption may reduce harm to baby's lungs due to smoking during pregnancy

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

Study examines link between nicotine dependence and likelihood to quit smoking after lung cancer screening

Researchers discover new disease mechanism in chronic tobacco smokers

Experts available to discuss subjects related to Ebola virus

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

First, marijuana. Are magic mushrooms next?

FDA approves new drug to treat MS in pediatric patients

Prenatal marijuana use can have consequences on infants' weight and behavior

FDA seeks order of permanent injunction to stop two stem cell clinics from marketing stem cell products

Lesbian, bisexual women have higher risk of developing type 2 diabetes, finds study

HCI announces opening of Center for HOPE for improving health among underserved populations

Study links occupational exposures with higher incidence of COPD

Scientists use X-ray laser to gain insights into structure of Alzheimer's proteins

Huntsman Cancer Institute opens Cancer Population Sciences and Huntsman Center for HOPE

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

Five facts to help teens make informed decisions about vaping

FDA authorizes marketing of Hemospray device for treating GI bleeding

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News